Cognizant Names Bram Schot to Board of Directors
Get Alerts CTSH Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.2%
Revenue Growth %: +4.1%
Join SI Premium – FREE
Seasoned public company executive brings strong operational, managerial and technological expertise
"We are pleased to welcome a leader of Bram's caliber to the Cognizant Board," said
The Board continues to strive towards optimizing its balance of director skills and tenures as part of its ongoing refreshment program. With the addition of
About
About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life. See how at www.cognizant.com or @cognizant.
Investor Relations Contact:
VP, Investor Relations
+1 551-220-8246
[email protected]
Media Contact:
VP, Corporate Communications
+1 475-223-2298
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/cognizant-names-bram-schot-to-board-of-directors-301787341.html
SOURCE
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Final OS Analysis Results from Phase III OptiTROP-Lung04 Study of Sacituzumab Tirumotecan (sac-TMT) Presented at 2026 ESMO
- 2026 ESMO | Innovent Presented Phase 1 Study Data for IBI3001, a First-in-Class EGFR/B7H3 Bispecific ADC
- The Results of Phase III OptiTROP-Lung06 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ESMO Oral Presentation and Simultaneously Published in The New England Journal of Medicine
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
The Carlyle GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share